Related references
Note: Only part of the references are listed.Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure
Rima Kamel et al.
NATURE REVIEWS CARDIOLOGY (2023)
Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure, and Hypertension in Mice and Humans
Andrii Boguslavskyi et al.
CIRCULATION (2021)
The cAMP-phosphodiesterase 4 (PDE4) controls β-adrenoceptor- and CFTR-dependent saliva secretion in mice
Abigail Boyd et al.
BIOCHEMICAL JOURNAL (2021)
Inhibition of cAMP-phosphodiesterase 4 (PDE4) potentiates the anesthetic effects of Isoflurane in mice
Ileana Aragon et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Successful induction of deep hypothermia by isoflurane anesthesia and cooling in a non-hibernator, the rat
Hiroki Shimaoka et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2021)
Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice
Abigail Boyd et al.
BIOLOGY-BASEL (2021)
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
Dean Paes et al.
PHARMACOLOGICAL REVIEWS (2021)
Advances in the Development of Phosphodiesterase-4 Inhibitors
Ting Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Inhibition of type 4 cAMP-phosphodiesterases (PDE4s) in mice induces hypothermia via effects on behavioral and central autonomous thermoregulation
Will McDonough et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench
Walter E. Rodriguez et al.
HEPATOLOGY (2019)
Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
George S. Baillie et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Role of cAMP and phosphodiesterase signaling in liver health and disease
Banrida Wahlang et al.
CELLULAR SIGNALLING (2018)
Protection against severe hypokalemia but impaired cardiac repolarization after intense rowing exercise in healthy humans receiving salbutamol
Tania Atanasovska et al.
JOURNAL OF APPLIED PHYSIOLOGY (2018)
Hypokalemia: a clinical update
Efstratios Kardalas et al.
ENDOCRINE CONNECTIONS (2018)
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Heng Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
The impact of hypothermia on serum potassium concentration: A systematic review
Sarah Buse et al.
RESUSCITATION (2017)
Physiology and pathophysiology of potassium homeostasis
Biff F. Palmer et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2016)
Na,K-ATPase regulation in skeletal muscle
Sergej Pirkmajer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective
Pierre Bobin et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2016)
Phosphodiesterase-4 inhibition as a therapeutic strategy for metabolic disorders
C. Wu et al.
OBESITY REVIEWS (2016)
Regulation of Potassium Homeostasis
Biff F. Palmer
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Roles of astrocytic Na+,K+-ATPase and glycogenolysis for K+ homeostasis in mammalian brain
Leif Hertz et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2015)
Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman
Andrii Boguslavskyi et al.
CARDIOVASCULAR RESEARCH (2014)
The Impact of Hypothermia on Emergence from Isoflurane Anesthesia in Orexin Neuron-Ablated Mice
Chiharu Kuroki et al.
ANESTHESIA AND ANALGESIA (2013)
PDE4 as a target for cognition enhancement
Wito Richter et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Novel regulation of cardiac Na pump via phospholemman
Davor Pavlovic et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Protein Kinase A and C Regulate Leak Potassium Currents in Freshly Isolated Vascular Myocytes from the Aorta
Sebastien Hayoz et al.
PLOS ONE (2013)
Astrocytic and neuronal accumulation of elevated extracellular K+ with a 2/3 K+/Na+ flux ratio-consequences for energy metabolism, osmolarity and higher brain function
Leif Hertz et al.
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2013)
Muscle Potassium and Potassium Losses During Hypokinesia in Healthy Subjects
Yuri F. Federenko et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2011)
A Critically Swift Response: Insulin-Stimulated Potassium and Glucose Transport in Skeletal Muscle
Kevin Ho
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Role of phospholemman phosphorylation sites in mediating kinase-dependent regulation of the Na+-K+-ATPase
Fei Han et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Hormonal and pharmacological modification of plasma potassium homeostasis
Torben Clausen
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2010)
The preclinical pharmacology of roflumilast - A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
Armin Hatzelmann et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C
William Fuller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Olga A. H. Reneerkens et al.
PSYCHOPHARMACOLOGY (2009)
The Role of Phosphodiesterases in Schizophrenia
Judith A. Siuciak
CNS DRUGS (2008)
Muscle K+, Na+, and Cl+ disturbances and Na+-K+ pump inactivation: implications for fatigue
Michael J. McKenna et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation
Elaine Huston et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Homeostatic regulation of kv1.2 potassium channel trafficking by cyclic AMP
Emilee C. Connors et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes
Stephanie Bibert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Skeletal muscle vasodilatation at the onset of exercise
Philip S. Clifford
JOURNAL OF PHYSIOLOGY-LONDON (2007)
cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system - A molecular toolbox for generating compartmentalized cAMP signaling
Miles D. Houslay et al.
CIRCULATION RESEARCH (2007)
FXYD proteins: new regulators of Na-k-ATPase
K Geering
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Phosphodiesterase-4 as a therapeutic target
MD Houslay et al.
DRUG DISCOVERY TODAY (2005)
Role of muscle in regulating extracellular [K+]
AA McDonough et al.
SEMINARS IN NEPHROLOGY (2005)
Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle
H Moriuchi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling
M Conti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
SLC Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The effect of hypothermia on isoflurane MAC in children
MZ Liu et al.
ANESTHESIOLOGY (2001)
Cyclic AMP regulates the HERG K+ channel by dual pathways
J Cui et al.
CURRENT BIOLOGY (2000)
Share Paper
